CTRI Number |
CTRI/2018/01/011476 [Registered on: 22/01/2018] Trial Registered Prospectively |
Last Modified On: |
23/03/2018 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
STUDY OF AYURVEDIC MANAGEMENT OF NEPHROTIC SYNDROME |
Scientific Title of Study
|
EVALUATION OF MULTI-PHASIC OPTIMIZED AYURVEDIC MANAGEMENT IN THE PATIENTS OF PRIMARY NEPHROTIC SYNDROME |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Vikas C Patel |
Designation |
PG Scholar |
Affiliation |
J S Ayurveda college, Nadiad. |
Address |
B/4, Kailashdham Society, B/H Purusottam nagar, Old Dumral Road, Nadiad. (387002) Dist.-Kheda. Gujarat. J S Ayurveda college, collage road, Nadiad. (387001) Dist- Kheda. Gujarat. Kheda GUJARAT 387002 India |
Phone |
9586582481 |
Fax |
|
Email |
drvikaspatel912@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr S N Gupta |
Designation |
MD(Ayu) Professor & HOD kayachikitsa department |
Affiliation |
J S Ayurveda college Nadiad |
Address |
J S Ayurveda college, collage road, Nadiad. (387001) Dist- Kheda.
Kheda GUJARAT 387001 India |
Phone |
9825261305 |
Fax |
|
Email |
guptayurveda@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Vikas C Patel |
Designation |
PG Scholar |
Affiliation |
J S Ayurveda college, Nadiad. |
Address |
B/4, Kailashdham Society, B/H Purusottam nagar, Old Dumral Road, Nadiad. (387002) Dist.-Kheda. Gujarat. J S Ayurveda college, collage road, Nadiad. (387001) Dist- Kheda. Gujarat. Kheda GUJARAT 387002 India |
Phone |
9586582481 |
Fax |
|
Email |
drvikaspatel912@gmail.com |
|
Source of Monetary or Material Support
|
J S Ayurveda college and P D Patel Ayurvedic Hospital, college road, Nadiad-387001 |
|
Primary Sponsor
|
Name |
J S Ayurveda college |
Address |
J S Ayurveda college, college Road, Nadiad. (387001) Dist-Kheda. Gujarat. |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Vikas C Patel |
P D Patel Ayurveda Hospital |
Kayachikitsa department, Room 204, Nadiad.(387001) Kheda, Gujarat. Kheda GUJARAT |
9586582481 9586582481 drvikaspatel912@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional ethics committee for human research |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Primary Nephrotic syndrome patients, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Ayurvedic classical herbal formulation |
1.Vardhamana pippali rasayana kalpa: Fine powder of pippali (Piper longum Linn.) will be given in increasing and tapering dose-pattern.
2.Virecana karma: Mridu virecana (purgation) will be performed with the help of eraṇá¸a sneha (oil of the seeds of Ricinus communis Linn.).
Oral Medications:
3.Gokshuradi guggulu – 3 tablets (each of 300 mg) 3 times in a day after food with warm water
4.Shuddha Shilajita – 5gm 2 times in a day with milk.
5.Haritakyadi kvatha – 40 ml 2 times in a day after food.
6.Rasayana churna – 3 gm 3 times in a day with water. |
Comparator Agent |
Not applicable |
Not applicable |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
50.00 Year(s) |
Gender |
Both |
Details |
1. Patient who have confirmed diagnosis of Primary type of nephrotic syndrome (idiopathic) of both the genders and between 18 to 50 years of age group. |
|
ExclusionCriteria |
Details |
1. Patients of nephrotic syndrome due to other disorders i.e SLE, Henoch Schonlein purpura, amyloidosis and infection with HIV, parvovirus B19 and hepatitis B and C viruses, Diabetes mellitus, Drug toxicity, any genetic disorders etc.
2. Patients having complication of nephrotic syndrome like CRF etc.
3. Patients who associated with some serious illness i.e. tuberculosis, cardio-vascular diseases, acute mental disorders, serious acute organic diseases, serious chronic co-morbidity, hypo or hyper thyroidism, Cushing’s syndrome, thromboembolic disorders etc.
4. Patients with an eGFR (glomerular filtration rate) less than 60 ml/min/1.73m2.
5. Female patients having pregnancy, lactating or post-delivery period.
6. Patients of nephrotic syndrome who are contraindicated for virecana. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Effect of Ayurvedic management in the patient of primary Nephrotic syndrome. |
Grade score of sign and symptoms along with laboratory investigation before treatment and after treatment of 28 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
nil |
nil |
|
Target Sample Size
|
Total Sample Size="10" Sample Size from India="10"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
24/01/2018 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
Not applicable.This thesis work will yet to be submit. |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
Evaluation the effectiveness of the Ayurvedic treatment in the patients of primary nephrotic syndrome is the main objective of study.Patients who fulfill the diagnostic and inclusive criteria (mentioned below) will be selected irrespective of demographic division from out-patient department (OPD) and in-patient department (IPD) of J S Ayurveda College and P D Patel Ayurveda Hospital, Nadiad. And then they will be treated with following treatment.Phase – 1 (first 13 days period): Vardhamana pippali rasayana kalpa: Fine powder of pippali(Piper longum Linn.) will be given in increasing and tapering dose-pattern. In this pattern 1 g powder of Piper longum will be given twice with honey on the first day. Every day the dose will be increased by 1 g eventually to reach to 5 g twice daily. The dose of 5 g will be kept for 5 days and then tapered down 1 g every day to finally reach 1 g again. This will take 13 days. Phase – 2 (14th to 16th day period): Virecana karma: On the 14th day mridu virecana (purgation) will be performed in the patients with the help of eranda sneha (oil of the seeds of Ricinus communis Linn.). The dose of eranda sneha will be 30 to 40 ml according to the patient’s koshtha(frequency and sensitivity of bowels). All the patients will be kept on the samsarjana krama (rest period with special diet) for next two days. Phase – 3 (17 th to 28 th day period): After the completion of purgation, following treatment will be given orally for next 12 days. 1. 1. Gokshuradi guggulu (Gokshura + Guggulu + Haritaki + Bibhitaki + Amalaki + Sunthi + Maricha + Musta)– 3 tablets (each of 300 mg) 3 times in a day after food with warm water. 2. Shuddha Shilajita– 5gm 2 times in a day with milk. 3. Haritakydi kvatha (Haritaki + Duralabha + Aragvadha + Gokshura + Pashanabheda)– 40 ml 2 times in a day after food. 4. Rasayana churna (Gokshura + Amalaki + Guduchi)– 3 gm 3 times in a day with water. Follow up - The patient will be instructed to come for a follow up on every 2 weeks for next 1 month. During follow-up period, all the patients will be instructed to take the oral medicaments except pippali as per the schedule at home along with pathyapathya.
|